Information Provided By:
Fly News Breaks for June 5, 2015
RARE
Jun 5, 2015 | 07:13 EDT
Canaccord raised its price target on Ultragenyx to $97 from $78, citing positive KRN23 data and a potential pathway for conditional EU approval based on EMA feedback. Canaccord believes Ultragenyx is "firing on all cylinders" and reiterated its Buy rating on the shares.
News For RARE From the Last 2 Days
There are no results for your query RARE